Effects of Compound Rhizoma Coptidis Capsule on the Expressions of Vascular Endothelial Growth Factor and mRNA in Renal Tissue of Rats with Early Diabetic Nephropathy

WEI Yu,LIU Sheng,TANG Li-qin,CHEN Li-ming,CHEN Xiang-qing,SHI Tian-lu
2008-01-01
Abstract:OBJECTIVE:To explore the effects of compound Rhizoma coptidis capsule on the expressions of vascular endothelial growth factor(VEGF)and mRNA in the kidney of rats with early diabetic nephropathy.METHODS:The rats were intraperitoneally administered with streptozotocin to establish early diabetic nephropathy model.Then the rats were randomly divided into five groups:normal control group,diabetic nephropathy model group,Xiaoke Pill(0.8 g·kg-1)group,CRCC-treated groups(2.18 g·kg-1 and 4.36 g·kg-1).The animals were intragastrically administered with corresponding drugs once daily.After 8 weeks,the fasting blood glucose,blood urea nitrogen and creatinine were measured and serum levels of insulin(Ins),α1-MG,β2-MG were determined by radioimmunoassay.Immunohistochemistry and RT-PCR were used to detect the expressions of VEGF and mRNA in the renal tissue of rats.RESULTS:In CRCC-treated groups,serum levels of FBG,α1-MG、β2-MG,BUN and Scr were markedly decreased(P<0.01),while the insulin level increased markedly(P<0.01),and the expressions of VEGF and mRNA in renal glomeruli and tubuli were decreased(P<0.05).CONCLUSION:CRCC can obviously improve renal function and decrease the overexpression of VEGF and mRNA in kidney tissue,and delay the progression of diabetic nephropathy in diabetic nephropathy model rats
What problem does this paper attempt to address?